EL

Eli Lilly and Company

Organization

Heard in 56 episodes across 28 shows since May 2026

Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana. Founded in 1876 by chemist and Civil War veteran Eli Lilly, the company develops, manufactures, and markets human pharmaceuticals globally.

Discussed inMarkets61%AI & Tech11%Politics11%Health & Science8%

Episodes

56
across 28 shows

This week

0
episodes on 0 shows

Expert statements

6
4 positive · 1 negative

Share of the conversation

Mentions of Eli Lilly and Company per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰1‰2‰3‰4‰Jul 11Aug 2Aug 25Sep 16Oct 8
Show the data
DayShare (7-day)Mentions
Jul 162.24‰3
Aug 50.79‰5
Aug 100.31‰1
Aug 120.07‰1
Aug 140.15‰3
Aug 170.19‰2
Aug 220.11‰1
Aug 230.14‰1
Aug 260.10‰1
Sep 30.06‰2
Sep 40.09‰1
Sep 80.14‰1
Sep 90.18‰1
Sep 100.14‰1
Sep 110.14‰1
Sep 130.17‰1
Sep 140.27‰4
Sep 210.22‰8
Sep 220.35‰5
Sep 230.40‰2
Sep 250.51‰4
Sep 280.32‰1
Sep 300.16‰1
Oct 30.08‰1
Oct 40.16‰3
Oct 50.16‰1
Oct 70.19‰2

The full trend: rank, tone and why it is trending →

What experts have said about Eli Lilly and Company

6 statements · 4 positive · 1 negative · 1 neutral

  1. Chloe MelleyNegativeAug 5, 2026· Stock Movers

    Eli Lilly’s weight-loss pill may affect Novo Nordisk’s outlook.

    “there's the question as well of how successful Eli Lilly is going to be with its own weight loss pill that it has”

    Listen at 1:59

    Open the episode · Novo Nordisk Drops, Next Jumps, Infineon Falls
  2. Avalon PurnellPositiveAug 5, 2026· Stock Movers

    Eli Lilly’s strong second-quarter results increased its 2026 sales guidance.

    “the firm's better than expected second quarter results led to a boost in 2026 sales guidance.”

    Listen at 1:59

    Open the episode · SpaceX Falls, Eli Lilly Jumps, Davita Slides as US Dialysis Revenue Misses Estimates
  3. Kristine AquinoPositiveAug 5, 2026· Stock Movers

    Eli Lilly raised revenue guidance because demand for weight-loss and diabetes medicines exceeded expectations.

    “They did boost their revenue guidance on the back of stronger than expected demand for for weight loss drugs and diabetes medicine.”

    Listen at 3:24

    Open the episode · AMD Slides, SpaceX Falls, Eli Lilly Jumps as Obesity Drug Boom Shows No Sign of Slowing

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

56 episodes featuring Eli Lilly and Company, newest first

Eli Lilly and Company · PodLume